Search
OptimizeRx Corp
OPRXAdd to Watchlist
6.050USD
-0.220-3.51%
Close 07-31 16:00（ET）Quotes delayed by 15 min
113.53MMarket Cap
16.38P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of OptimizeRx Corp is 8.67, ranking 24 out of 485 in the Software & IT Services industry. The average price target is 24.00, with a high of 32.00 and a low of 17.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
12.400
Target Price
+94.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
105
Total
8
Median
14
Average
Company name
Ratings
Analysts
OptimizeRx Corp
OPRX
6
Meta Platforms Inc
META
65
Alphabet Inc Class A
GOOGL
62
Uber Technologies Inc
UBER
55
Netflix Inc
NFLX
52
Lyft Inc
LYFT
50
1
2
3
...
21
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is OptimizeRx Corp's expected revenue for the next quarter?
OptimizeRx Corp's expected revenue is 20.20M.
What is OptimizeRx Corp's price target?
Analysts forecast that OptimizeRx Corp's price target is USD 24.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 17.00.
How have OptimizeRx CorpOPRX's recent earnings per share performed?
The market expectation was USD -0.03, while OptimizeRx CorpOPRX's earnings per share (EPS) for the previous quarter was USD 0.27. EPS for the next quarter is expected at USD 0.12.
What is the analyst rating for OptimizeRx Corp?
Based on the ratings of OptimizeRx Corp's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.